Location
Philadelphia, PA
Start Date
11-5-2022 1:00 PM
End Date
11-5-2022 4:00 PM
Description
Introduction: The field of orthopaedic oncology has trailed in defining trends in reported outcome measures (ROMs) over the last decade. Although the Musculoskeletal Tumor Society (MSTS) Score is a well-recognized ROM, new ROMs developed and established in literature have created difficulty in identifying the standard ROM within the field. The aim of our study is to identify trends in the use of ROMs in orthopaedic oncology over time, as well as the frequency and distribution among specific pathologies and orthopaedic journals.
Methods: A systematic review was conducted of all original articles reporting on topics relating to orthopaedic oncology in five orthopaedic journals over a ten-year period (2011-2021). The ROM used in all of the articles was recorded, in addition to study date, study design, clinical topic/pathology, and level of evidence.
Results: Out of 197 articles reviewed that included at least one clinical outcome rating instrument, the most popular tools used were the MSTS (57%) and the Toronto Extremity Salvage (TESS) Score (12.5%), followed by the 36-Item Short Form (SF-36) Survey (5.11%), and Patient Reported Outcomes Measurement Information System (PROMIS) (3.14%).
Conclusion: MSTS is consistently the most widely used ROM in orthopaedic oncology. Data from this study reflects that the reporting of ROMs in orthopaedic oncology is also sparse compared to other orthopaedic subspecialties. It is important to note the need for consensus for standardization of measuring outcome, and that the addition of PROMIS may provide clinicians a better perspective of patients’ overall outcome physically and mentally.
Embargo Period
6-1-2022
Included in
Trends in Patient Outcome Scores in Orthopaedic Oncology: A Systematic Review
Philadelphia, PA
Introduction: The field of orthopaedic oncology has trailed in defining trends in reported outcome measures (ROMs) over the last decade. Although the Musculoskeletal Tumor Society (MSTS) Score is a well-recognized ROM, new ROMs developed and established in literature have created difficulty in identifying the standard ROM within the field. The aim of our study is to identify trends in the use of ROMs in orthopaedic oncology over time, as well as the frequency and distribution among specific pathologies and orthopaedic journals.
Methods: A systematic review was conducted of all original articles reporting on topics relating to orthopaedic oncology in five orthopaedic journals over a ten-year period (2011-2021). The ROM used in all of the articles was recorded, in addition to study date, study design, clinical topic/pathology, and level of evidence.
Results: Out of 197 articles reviewed that included at least one clinical outcome rating instrument, the most popular tools used were the MSTS (57%) and the Toronto Extremity Salvage (TESS) Score (12.5%), followed by the 36-Item Short Form (SF-36) Survey (5.11%), and Patient Reported Outcomes Measurement Information System (PROMIS) (3.14%).
Conclusion: MSTS is consistently the most widely used ROM in orthopaedic oncology. Data from this study reflects that the reporting of ROMs in orthopaedic oncology is also sparse compared to other orthopaedic subspecialties. It is important to note the need for consensus for standardization of measuring outcome, and that the addition of PROMIS may provide clinicians a better perspective of patients’ overall outcome physically and mentally.
Comments
Presented by Kelsey Martin.